特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

塞栓療法の世界市場:2025年までの適応症別、製品別、タイプ別、エンドユーザー別、地域別予測および機会

Global Embolotherapy Market By Indication, By Product, By Type, By End-User, By Region, Forecast & Opportunities, 2025

発行 TechSci Research 商品コード 934748
出版日 ページ情報 英文 112 Pages
納期: お問合せ
価格
本日の銀行送金レート: 1USD=106.59円で換算しております。

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

塞栓療法の世界市場:2025年までの適応症別、製品別、タイプ別、エンドユーザー別、地域別予測および機会 Global Embolotherapy Market By Indication, By Product, By Type, By End-User, By Region, Forecast & Opportunities, 2025
出版日: 2020年05月01日 ページ情報: 英文 112 Pages
概要

世界の塞栓療法市場は、慢性疾患の発生率の上昇、患者集団の増加、医療費の急増などの要因により、予測期間中に大幅なCAGRで成長すると予想されます。さらに、塞栓療法デバイスの急速な技術進歩も2025年まで市場成長を後押しすると予想されます。

当レポートは、世界の塞栓療法市場を調査したもので、各地域市場の展望、市場力学、主要動向、競合情勢などの情報を提供するとともに、戦略的提言を示しています。

目次

第1章 製品の概要

第2章 調査手法

第3章 COVID-19が世界市場に与える影響

第4章 エグゼクティブサマリー

第5章 お客様の声

第6章 世界市場の展望

  • 市場規模と予測
    • 金額・数量ベース
  • 市場シェアと予測
    • 適応症(がん、消化器疾患、神経疾患、末梢血管疾患、泌尿器科および腎臓病)
    • 製品別(塞栓剤(塞栓コイル、塞栓プラグシステム、液体塞栓剤、ミクロスフェア、取り外し可能なバルーン)、サポートデバイス(マイクロカテーテル、ガイドワイヤー))
    • タイプ別(化学塞栓術、放射線塞栓術、動脈塞栓術、併用)
    • エンドユーザー(病院、クリニック、外来手術センター、その他)
    • 会社別(2019)
    • 地域別
  • 市場魅力指数

第7章 アジア太平洋市場の展望

  • 市場規模と予測
    • 金額・数量ベース
  • 市場シェアと予測
    • 適応症別
    • 塞栓剤別
    • タイプ別
    • エンドユーザー別
    • 国別
  • 市場魅力指数
  • アジア太平洋:国分析
    • 中国市場の展望
    • インド市場の展望
    • 日本市場の展望
    • 韓国市場の展望
    • シンガポール市場の展望
    • オーストラリア市場の展望

第8章 欧州市場の展望

  • 市場規模と予測
    • 金額・数量ベース
  • 市場シェアと予測
    • 適応症別
    • 塞栓剤別
    • タイプ別
    • エンドユーザー別
    • 国別
  • 市場魅力指数
  • 欧州:国分析
    • フランス市場の展望
    • ドイツ市場の展望
    • 英国市場の展望
    • イタリア市場の展望
    • ロシア市場の展望
    • スペイン市場の展望

第9章 北米市場の展望

  • 市場規模と予測
    • 金額・数量ベース
  • 市場シェアと予測
    • 適応症別
    • 塞栓剤別
    • タイプ別
    • エンドユーザー別
    • 国別
  • 市場魅力指数
  • 北米:国分析
    • 米国市場の展望
    • メキシコ市場の展望
    • カナダ市場の展望

第10章 南米市場の展望

  • 市場規模と予測
    • 金額・数量ベース
  • 市場シェアと予測
    • 適応症別
    • 塞栓剤別
    • タイプ別
    • エンドユーザー別
    • 国別
  • 市場魅力指数
  • 南米:国分析
    • ブラジル市場の展望
    • アルゼンチン市場の展望
    • コロンビア市場の展望

第11章 中東・アフリカ市場の展望

  • 市場規模と予測
    • 金額・数量ベース
  • 市場シェアと予測
    • 適応症別
    • 塞栓剤別
    • タイプ別
    • エンドユーザー別
    • 国別
  • 市場魅力指数
  • 中東・アフリカ:国分析
    • 南アフリカ市場の展望
    • サウジアラビア市場の展望
    • UAE 市場の展望

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場動向と動向

第14章 競合情勢

  • 競合展望
  • 企業プロファイル(主要企業)
    • Abbott Laboratories
    • ABK Biomedical Inc
    • Acandis GmbH
    • AngioDynamics Inc
    • Becton Dickinson and Company
    • Boston Scientific Corporation
    • Cook Medical
    • Guerbet
    • Imbiotechnologies Ltd.
    • Johnson & Johnson
    • カネカ
    • Medtronic
    • Meril Life Sciences Pvt. Ltd.
    • Merit Medical Systems
    • Merit Medical Systems, Inc.
    • Penumbra, Inc.
    • Simbionix USA Corporation
    • Sirtex Medical Limited
    • Stryker Corporation
    • Terumo Corporation

第15章 戦略的推奨事項

第16章 免責事項

目次
Product Code: 4666

Global embolotherapy market is expected to register significant CAGR during the forecast period owing to factors like rising incidence of chronic diseases, increasing patient pool and surging healthcare spending. Additionally, rapid technological advancements in embolotherapy devices is also anticipated to boost the market growth until 2025.

Embolotherapy is a type of endovascular treatment used for controlling bleeding and reduce tumor by restricting or blocking abnormal blood cells. To achieve blocking, embolotherapy uses minimally invasive methods and other embolic agents like gel foam, coils, balloons and angiographic catheters to achieve positive results. Additionally, adoption of embolic procedures for the management of various diseases is increasing rapidly as most of the patients who are diagnosed at intermediate stage and advanced stage, do not respond to curative therapies.

The global embolotherapy market faces some restraints which include risks and challenges associated with embolization and dearth of skilled radiologists. Also, unfavorable regulatory scenario might also pose challenge to the growth of embolotherapy market.

The global embolotherapy market is segmented based on indication, product, type, end-user and region. Based on end-user, the market is segmented into hospitals, clinics, ambulatory surgical centers and others. In 2019, hospitals category accounted for the largest market share in the global embolotherapy market. The reason behind this can be attributed to growing adoption of minimally invasive procedures promoted by the hospitals.

Major players operating in the global embolotherapy market include Abbott Laboratories , ABK Biomedical Inc, Acandis GmbH, AngioDynamics Inc, Becton Dickinson and Company, Boston Scientific Corporation, Cook Medical, Guerbet, Imbiotechnologies Ltd., Johnson & Johnson, Kaneka Corporation, Medtronic, Meril Life Sciences Pvt. Ltd., Merit Medical Systems, Inc., Penumbra, Inc., Simbionix USA Corporation, Sirtex Medical Limited, Stryker Corporation, Terumo Corporation and others. The companies are engaging in research and development of new products to increase their market share. Also, other growth strategies like partnerships, and strategic acquisitions are helping companies to boost their presence in the global embolotherapy market.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and forecast the market size of global embolotherapy market.
  • To classify and forecast global embolotherapy market based on indication, product, type, end-user and regional distribution.
  • To identify drivers and challenges for global embolotherapy market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global embolotherapy market.
  • To conduct pricing analysis for global embolotherapy market.
  • To identify and analyze the profile of leading players operating in global embolotherapy market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals/clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals/clinics and presence of all major players across the globe.

TechSci Research calculated the market size of global embolotherapy market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Embolotherapy hospitals/clinics, research organizations and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to embolotherapy
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global embolotherapy market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Indication:

Cancer

Gastrointestinal Disorders

Neurological Diseases

Peripheral Vascular Disease

Urological & Nephrological Disorders

  • Market, By Product:

Embolic Agents

  • Embolic Coils
  • Embolic Plug Systems
  • Liquid Embolic Agents
  • Microspheres
  • Detachable Balloons

Support Devices

  • Microcatheters
  • Guidewires
  • Market, By Type:

Chemoembolization

Radioembolization

Arterial Embolization

Combination

  • Market, By End-User:

Hospitals

Clinics

Ambulatory Surgical Centers

Others

  • Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global embolotherapy market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Embolotherapy Market

4. Executive Summary

5. Voice of Customer

6. Global Embolotherapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Indication (Cancer, Gastrointestinal Disorders, Neurological Diseases, Peripheral Vascular Disease, Urological & Nephrological Disorders)
    • 6.2.2. By Product (Embolic Agents (Embolic Coils, Embolic Plug Systems, Liquid Embolic Agents, Microspheres, Detachable Balloons), Support Devices (Microcatheters, Guidewires))
    • 6.2.3. By Type (Chemoembolization, Radioembolization, Arterial embolization, Combination)
    • 6.2.4. By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Others)
    • 6.2.5. By Company (2019)
    • 6.2.6. By Region
  • 6.3. Market Attractiveness Index

7. Asia-Pacific Embolotherapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Indication
    • 7.2.2. By Embolic agents
    • 7.2.3. By Types
    • 7.2.4. By End-User
    • 7.2.5. By Country
  • 7.3. Market Attractiveness Index
  • 7.4. Asia-Pacific: Country Analysis
    • 7.4.1. China Embolotherapy Market Outlook
      • 7.4.1.1. Market Size & Forecast
        • 7.4.1.1.1. By Value
      • 7.4.1.2. Market Share & Forecast
        • 7.4.1.2.1. By Indication
        • 7.4.1.2.2. By Embolic agents
        • 7.4.1.2.3. By Types
        • 7.4.1.2.4. By End-User
    • 7.4.2. India Embolotherapy Market Outlook
      • 7.4.2.1. Market Size & Forecast
        • 7.4.2.1.1. By Value
      • 7.4.2.2. Market Share & Forecast
        • 7.4.2.2.1. By Indication
        • 7.4.2.2.2. By Embolic agents
        • 7.4.2.2.3. By Types
        • 7.4.2.2.4. By End-User
    • 7.4.3. Japan Embolotherapy Market Outlook
      • 7.4.3.1. Market Size & Forecast
        • 7.4.3.1.1. By Value
      • 7.4.3.2. Market Share & Forecast
        • 7.4.3.2.1. By Indication
        • 7.4.3.2.2. By Embolic agents
        • 7.4.3.2.3. By Types
        • 7.4.3.2.4. By End-User
    • 7.4.4. South Korea Embolotherapy Market Outlook
      • 7.4.4.1. Market Size & Forecast
        • 7.4.4.1.1. By Value
      • 7.4.4.2. Market Share & Forecast
        • 7.4.4.2.1. By Indication
        • 7.4.4.2.2. By Embolic agents
        • 7.4.4.2.3. By Types
        • 7.4.4.2.4. By End-User
    • 7.4.5. Singapore Embolotherapy Market Outlook
      • 7.4.5.1. Market Size & Forecast
        • 7.4.5.1.1. By Value
      • 7.4.5.2. Market Share & Forecast
        • 7.4.5.2.1. By Indication
        • 7.4.5.2.2. By Embolic agents
        • 7.4.5.2.3. By Types
        • 7.4.5.2.4. By End-User
    • 7.4.6. Australia Embolotherapy Market Outlook
      • 7.4.6.1. Market Size & Forecast
        • 7.4.6.1.1. By Value
      • 7.4.6.2. Market Share & Forecast
        • 7.4.6.2.1. By Indication
        • 7.4.6.2.2. By Embolic agents
        • 7.4.6.2.3. By Types
        • 7.4.6.2.4. By End-User

8. Europe Embolotherapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Indication
    • 8.2.2. By Embolic agents
    • 8.2.3. By Types
    • 8.2.4. By End-User
    • 8.2.5. By Country
  • 8.3. Market Attractiveness Index
  • 8.4. Europe: Country Analysis
    • 8.4.1. France Embolotherapy Market Outlook
      • 8.4.1.1. Market Size & Forecast
        • 8.4.1.1.1. By Value
      • 8.4.1.2. Market Share & Forecast
        • 8.4.1.2.1. By Indication
        • 8.4.1.2.2. By Embolic agents
        • 8.4.1.2.3. By Types
        • 8.4.1.2.4. By End-User
    • 8.4.2. Germany Embolotherapy Market Outlook
      • 8.4.2.1. Market Size & Forecast
        • 8.4.2.1.1. By Value
      • 8.4.2.2. Market Share & Forecast
        • 8.4.2.2.1. By Indication
        • 8.4.2.2.2. By Embolic agents
        • 8.4.2.2.3. By Types
        • 8.4.2.2.4. By End-User
    • 8.4.3. United Kingdom Embolotherapy Market Outlook
      • 8.4.3.1. Market Size & Forecast
        • 8.4.3.1.1. By Value
      • 8.4.3.2. Market Share & Forecast
        • 8.4.3.2.1. By Indication
        • 8.4.3.2.2. By Embolic agents
        • 8.4.3.2.3. By Types
        • 8.4.3.2.4. By End-User
    • 8.4.4. Italy Embolotherapy Market Outlook
      • 8.4.4.1. Market Size & Forecast
        • 8.4.4.1.1. By Value
      • 8.4.4.2. Market Share & Forecast
        • 8.4.4.2.1. By Indication
        • 8.4.4.2.2. By Embolic agents
        • 8.4.4.2.3. By Types
        • 8.4.4.2.4. By End-User
    • 8.4.5. Russia Embolotherapy Market Outlook
      • 8.4.5.1. Market Size & Forecast
        • 8.4.5.1.1. By Value
      • 8.4.5.2. Market Share & Forecast
        • 8.4.5.2.1. By Indication
        • 8.4.5.2.2. By Embolic agents
        • 8.4.5.2.3. By Types
        • 8.4.5.2.4. By End-User
    • 8.4.6. Spain Embolotherapy Market Outlook
      • 8.4.6.1. Market Size & Forecast
        • 8.4.6.1.1. By Value
      • 8.4.6.2. Market Share & Forecast
        • 8.4.6.2.1. By Indication
        • 8.4.6.2.2. By Embolic agents
        • 8.4.6.2.3. By Types
        • 8.4.6.2.4. By End-User

9. North America Embolotherapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Indication
    • 9.2.2. By Embolic agents
    • 9.2.3. By Types
    • 9.2.4. By End-User
    • 9.2.5. By Country
  • 9.3. Market Attractiveness Index
  • 9.4. North America: Country Analysis
    • 9.4.1. United States Embolotherapy Market Outlook
      • 9.4.1.1. Market Size & Forecast
        • 9.4.1.1.1. By Value
      • 9.4.1.2. Market Share & Forecast
        • 9.4.1.2.1. By Indication
        • 9.4.1.2.2. By Embolic agents
        • 9.4.1.2.3. By Types
        • 9.4.1.2.4. By End-User
    • 9.4.2. Mexico Embolotherapy Market Outlook
      • 9.4.2.1. Market Size & Forecast
        • 9.4.2.1.1. By Value
      • 9.4.2.2. Market Share & Forecast
        • 9.4.2.2.1. By Indication
        • 9.4.2.2.2. By Embolic agents
        • 9.4.2.2.3. By Types
        • 9.4.2.2.4. By End-User
    • 9.4.3. Canada Embolotherapy Market Outlook
      • 9.4.3.1. Market Size & Forecast
        • 9.4.3.1.1. By Value
      • 9.4.3.2. Market Share & Forecast
        • 9.4.3.2.1. By Indication
        • 9.4.3.2.2. By Embolic agents
        • 9.4.3.2.3. By Types
        • 9.4.3.2.4. By End-User

10. South America Embolotherapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Indication
    • 10.2.2. By Embolic agents
    • 10.2.3. By Types
    • 10.2.4. By End-User
    • 10.2.5. By Country
  • 10.3. Market Attractiveness Index
  • 10.4. South America: Country Analysis
    • 10.4.1. Brazil Embolotherapy Market Outlook
      • 10.4.1.1. Market Size & Forecast
        • 10.4.1.1.1. By Value
      • 10.4.1.2. Market Share & Forecast
        • 10.4.1.2.1. By Indication
        • 10.4.1.2.2. By Embolic agents
        • 10.4.1.2.3. By Types
        • 10.4.1.2.4. By End-User
    • 10.4.2. Argentina Embolotherapy Market Outlook
      • 10.4.2.1. Market Size & Forecast
        • 10.4.2.1.1. By Value
      • 10.4.2.2. Market Share & Forecast
        • 10.4.2.2.1. By Indication
        • 10.4.2.2.2. By Embolic agents
        • 10.4.2.2.3. By Types
        • 10.4.2.2.4. By End-User
    • 10.4.3. Colombia Embolotherapy Market Outlook
      • 10.4.3.1. Market Size & Forecast
        • 10.4.3.1.1. By Value
      • 10.4.3.2. Market Share & Forecast
        • 10.4.3.2.1. By Indication
        • 10.4.3.2.2. By Embolic agents
        • 10.4.3.2.3. By Types
        • 10.4.3.2.4. By End-User

11. Middle East and Africa Embolotherapy Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value & Volume
  • 11.2. Market Share & Forecast
    • 11.2.1. By Indication
    • 11.2.2. By Embolic agents
    • 11.2.3. By Types
    • 11.2.4. By End-User
    • 11.2.5. By Country
  • 11.3. Market Attractiveness Index
  • 11.4. MEA: Country Analysis
    • 11.4.1. South Africa Embolotherapy Market Outlook
      • 11.4.1.1. Market Size & Forecast
        • 11.4.1.1.1. By Value
      • 11.4.1.2. Market Share & Forecast
        • 11.4.1.2.1. By Indication
        • 11.4.1.2.2. By Embolic agents
        • 11.4.1.2.3. By Types
        • 11.4.1.2.4. By End-User
    • 11.4.2. Saudi Arabia Embolotherapy Market Outlook
      • 11.4.2.1. Market Size & Forecast
        • 11.4.2.1.1. By Value
      • 11.4.2.2. Market Share & Forecast
        • 11.4.2.2.1. By Indication
        • 11.4.2.2.2. By Embolic agents
        • 11.4.2.2.3. By Types
        • 11.4.2.2.4. By End-User
    • 11.4.3. UAE Embolotherapy Market Outlook
      • 11.4.3.1. Market Size & Forecast
        • 11.4.3.1.1. By Value
      • 11.4.3.2. Market Share & Forecast
        • 11.4.3.2.1. By Indication
        • 11.4.3.2.2. By Embolic agents
        • 11.4.3.2.3. By Types
        • 11.4.3.2.4. By End-User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Players Profiled (Leading Companies)
    • 14.2.1. Abbott Laboratories
    • 14.2.2. ABK Biomedical Inc
    • 14.2.3. Acandis GmbH
    • 14.2.4. AngioDynamics Inc
    • 14.2.5. Becton Dickinson and Company
    • 14.2.6. Boston Scientific Corporation
    • 14.2.7. Cook Medical
    • 14.2.8. Guerbet
    • 14.2.9. Imbiotechnologies Ltd.
    • 14.2.10. Johnson & Johnson
    • 14.2.11. Kaneka Corporation
    • 14.2.12. Medtronic
    • 14.2.13. Meril Life Sciences Pvt. Ltd.
    • 14.2.14. Merit Medical Systems
    • 14.2.15. Merit Medical Systems, Inc.
    • 14.2.16. Penumbra, Inc.
    • 14.2.17. Simbionix USA Corporation
    • 14.2.18. Sirtex Medical Limited
    • 14.2.19. Stryker Corporation
    • 14.2.20. Terumo Corporation

15. Strategic Recommendations

16. About Us & Disclaimer